Dr. Daniel H. Darmadi, MD
Gastroenterology (Gastroenterology Physician)
- Medicare participating
At a glance
- Medical school
- Saint Louis University School of Medicine (1995)
- Years since graduation
- 31
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 491
Licensed in Texas since 2001, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1995Medical school: Saint Louis University School of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gastroenterology Physician primary
TX license L2212 (first issued 2001; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Memorial Hermann Hospital System Houston, TX
- HCA Houston Healthcare Southeast Pasadena, TX
Medical groups
- Texas Digestive Disease Consultants, PLLC (608 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 491
- Services billed
- 2,388
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 346 | 235 |
| Established patient office or other outpatient visit, 30-39 minutes | 258 | 177 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 201 | 188 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 183 | 96 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 139 | 17 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 90 | 89 |
| Biopsy of large bowel using a flexible endoscope | 88 | 87 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 82 | 81 |
| New patient office or other outpatient visit, 30-44 minutes | 77 | 77 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 73 | 17 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Esomeprazole Magnesium Other prescribers in Houston, TX | 711 |
| Pantoprazole Sodium Other prescribers in Houston, TX | 560 |
| Omeprazole Other prescribers in Houston, TX | 550 |
| Famotidine Other prescribers in Houston, TX | 239 |
| Gavilyte-C (peg3350/sod sulf,bicarb,cl/kcl) Other prescribers in Houston, TX | 198 |
| Linzess (linaclotide) Other prescribers in Houston, TX | 188 |
| Dicyclomine Hcl Other prescribers in Houston, TX | 154 |
| Sutab (sod sulf/pot chloride/mag sulf) | 136 |
| Metoclopramide Hcl Other prescribers in Houston, TX | 133 |
| Sod Sulf-Potass Sulf-Mag Sulf (sodium, potassium,mag sulfates) Other prescribers in Houston, TX | 115 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 15 companies reported 147 payments worth $2,862 in total to this clinician.
| AbbVie Inc. | $886 |
|---|---|
| Madrigal Pharmaceuticals | $366 |
| Takeda Pharmaceuticals U.S.A., Inc. | $343 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $255 |
| Gilead Sciences, Inc. | $232 |
| Janssen Biotech, Inc. | $212 |
| Celltrion USA Inc. | $175 |
| Aimmune Therapeutics, Inc. | $136 |
| Food and Beverage | $2,862 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.